Log in or Sign up for Free to view tailored content for your specialty!
Rheumatoid Arthritis News
Depression risk elevated in both seropositive, seronegative rheumatoid arthritis
Patients with rheumatoid arthritis — either seropositive or seronegative — demonstrate a 1.66-fold higher risk for depression vs. healthy controls, according to data published in JAMA Network Open.
FDA approves Acthar Gel SelfJect injector in autoimmune, inflammatory conditions
The FDA has approved a supplemental new drug application for an Acthar Gel injector for the treatment of several chronic and acute inflammatory and autoimmune conditions, according to the manufacturer.
Log in or Sign up for Free to view tailored content for your specialty!
Six biomarkers could predict CVD risk in patients with rheumatoid arthritis
Six biomarkers were associated with baseline and treatment-associated changes in arterial inflammation in patients with rheumatoid arthritis and could be used to predict CVD risk in that population, researchers reported.
FDA approves Simlandi as third interchangeable Humira biosimilar
The FDA has approved Simlandi as the third interchangeable biosimilar to Humira following a rejection in April 2023 stemming from issues at the developer’s manufacturing facility.
Rheumatology meets placebo-nocebo science: At last!
I am thrilled to introduce our cover story this month, “‘Exploring the Power of Their Mind’: Data May Offer Clues to Harnessing the Placebo Effect,” to the readers of Healio Rheumatology. I say this for several reasons.
Wnt, neutrophil extracellular traps emerging as ‘important’ rheumatoid arthritis targets
SCOTTSDALE, Ariz. — The Wnt signaling pathway, neutrophil extracellular traps and PRIME cells represent “extremely important” emerging targets in rheumatoid arthritis, according to a speaker here.
US Veterans Affairs to replace Humira with biosimilar on national formulary
The U.S. Department of Veterans Affairs will replace Humira with the biosimilar Hadlima on its national formulary, according to a press release from Organon, which markets biosimilar.
‘Double negative’ B cells may predict abatacept response in rheumatoid arthritis
SCOTTSDALE, Ariz. — Patients with rheumatoid arthritis who had a decrease in a certain type of B cell that fails to express immunoglobulin D and CD27 saw clinical improvement with abatacept, according to data presented here.
Gut microbiome dictates DMARD response in RA; DMARDs partly restore microbiota diversity
Gut microbiota profiles in stool samples of patients with rheumatoid arthritis predicted their response to disease-modifying antirheumatic drugs, according to data in Rheumatology.
Biologic DMARD usage almost flat since 2008 among patients with RA, breast cancer
Among patients with rheumatoid arthritis diagnosed with breast cancer, the utilization of TNF inhibitors and other biologic disease-modifying antirheumatic drugs has not risen for more than a decade, according to data published in Arthritis Care & Research.
-
Headline News
‘We have a home’: Physician aims to create network of women allergists
November 14, 20245 min read -
Headline News
Diversified portfolios allow for ‘smoother ride’
November 14, 20243 min read -
Headline News
Predelivery concussion linked to increased risk for severe maternal mental illness
November 12, 20242 min read
-
Headline News
‘We have a home’: Physician aims to create network of women allergists
November 14, 20245 min read -
Headline News
Diversified portfolios allow for ‘smoother ride’
November 14, 20243 min read -
Headline News
Predelivery concussion linked to increased risk for severe maternal mental illness
November 12, 20242 min read